1. Osteogenic growth peptide enhances osteogenic differentiation of human periodontal ligament stem cells
- Author
-
Steven Dwi Purbantoro, Thanaphum Osathanon, Sirirat Nantavisai, and Chenphop Sawangmake
- Subjects
Osteogenic growth peptide (OGP) ,Human periodontal ligament stem cells (hPDLSCs) ,Osteogenic differentiation ,Bone regeneration ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Bone tissue engineering consists of three major components namely cells, scaffolds, and signaling molecules to improve bone regeneration. These integrated principles can be applied in patients suffered from bone resorption diseases, such as osteoporosis and periodontitis. Osteogenic growth peptide (OGP) is a fourteen-amino acid sequence peptide that has the potential to regenerate bone tissues. This study aimed to disseminate the osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) with OGP treatment. OGP was elaborated for proliferation, cytotoxicity, osteogenic differentiation effects, and the involvement of osteogenic related signaling pathways in vitro. This study found that OGP at lower concentration shows better effects on cytotoxicity and proliferation. Moreover, OGP at concentration 0.01 nM had the most potential to differentiate hPDLSCs toward osteogenic lineage comparing with higher concentrations of OGP. The phenomenon was mainly involving transforming growth factor-beta (TGF-β), bone morphogenetic protein (BMP), Hedgehog, and Wingless-related (Wnt) pathways. Further, SB-431542 treatment demonstrated the partial involvement of OGP in regulating osteogenic differentiation of hPDLSCs. In conclusion, OGP at low concentration enhances osteogenic differentiation of hPDLSCs by governing TGF-β signaling pathway.
- Published
- 2022
- Full Text
- View/download PDF